BIOLASE Inc. (BIOL): Kapitalisasi marang pendapatan
BIOLASE, Inc. (BIOL) ensures precision equipment assembly in compliance with RoHS standards. The cost-to-sales ratio reflects the current market valuation, where the parameter is 0.00. Leadership in the painless treatment niche with Waterlase makes the brand's systems highly sought after in premium clinics, while the implementation of energy-efficient production cycles and the minimization of plastic confirm the company's commitment to environmental responsibility.
Rincian analitis perusahaan Biolase, Inc. (BIOL)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal BIOLASE, Inc.|BIOL - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Biolase Inc.|BIOL - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Biolase, Inc.|BIOL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan BIOLASE|Rasio jangkoan perantara biolase.com
- data bathi lan kelipatan valuasi:
BIOL - Bathi resik|Bathi resik sing dikarepake BIOLASE, Inc.|BIOL - Rasio rega marang bathi|Pangali forward rega marang bathi BIOLASE Inc.|BIOL - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Biolase, Inc.|BIOL - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan BIOLASE|BIOL - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan biolase.com|BIOL - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep BIOLASE, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:BIOL biolase.com
The P/S multiple determines the market value of one dollar of revenue, allowing an investor to assess the degree of overpayment for a business regardless of current profitability. By analyzing the price-to-sales ratio, one can understand the premium at which the market values the leadership of BIOLASE (BIOL) in the painless dental laser segment and the willingness of capital to pay for exceptional brand authority.
Pesaing BIOLASE, Inc.
BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (Iradimed) - Kapitalisasi marang pendapatan|Embecta Health - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Diabetes Care) - Multiplikator P/S|Rega marang dodolan axogeninc.com AXGN|Rasio rega marang pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Multiplikator rega marang pendapatan|Bioventus Corp - Kapitalisasi marang pendapatan|Multiplikator P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator P/S|Koefisien rega marang pendapatan blade.com SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Inc)|Rasio rega marang pendapatan ClearPoint Neuro Inc.|Kapitalisasi marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator P/S STIM|SGHT - Rega marang dodolan|Rasio rega marang pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Rasio kapitalisasi marang pendapatan|NSPR: Kapitalisasi marang pendapatan|Jin Medical International - Kapitalisasi marang volume dodolan|VANI: Multiplikator P/S|XTNT (Xtant Medical) - Rasio rega marang pendapatan|NMTC (NeuroOne Medical Technologies Corporation) - Multiplikator P/S|Modular Med (MODD) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Myomo, Inc (MYO)|COCH - Rega marang dodolan|Rasio rega marang pendapatan Vivos Therapeutics VVOS|envveno.com - Rasio rega marang pendapatan|SINTX Technologies - Multiplikator P/S|TNON - Multiplikator P/S|ReWalk Robotics Ltd (LFWD) - Rasio rega marang pendapatan|AMIX - Koefisien rega marang pendapatan|IVF (INVO Fertility Inc) - Multiplikator P/S|Rega marang dodolan bonebiologics.com BBLG|Kapitalisasi marang pendapatan AXNX (Axonics)|DYNT (dynatronics.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S FNA (Paragon 28)|Koefisien rega marang pendapatan INVO Bioscience Inc. (INVO)
